SCHEMBL7567165

SCHEMBL7567165

CCCCCN1CC[C@H]1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.45
ACE P12821 1/20 0.41
S1PR4 O95977 1/20 0.41
S1PR1 P21453 1/20 0.41
S1PR3 Q99500 1/20 0.41
S1PR5 Q9H228 1/20 0.41
KCNH2 Q12809 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
GBA2 Q9HCG7 2/20 0.40
NR1I2 O75469 1/20 0.40
BCHE P06276 5/20 0.40
OPRD1 P41143 1/20 0.39
POLB P06746 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GNAI3 P08754 2/20 0.37
GNAO1 P09471 2/20 0.37
GNAI1 P63096 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3880995 1.00 GBA1 (0.45) GBA1ACES1PR4S1PR1S1PR3
SCHEMBL7132021 1.00 GBA1 (0.45) GBA1ACES1PR4S1PR1S1PR3
SCHEMBL28572785 0.98 GBA1 (0.47) GBA1ACES1PR4S1PR1S1PR3
SCHEMBL5702265 0.94 GBA2 (0.45) GBA1ACES1PR4S1PR1S1PR3
SCHEMBL5701883 0.94 GBA2 (0.45) GBA1ACES1PR4S1PR1S1PR3
SCHEMBL1381895 0.89 NR1I2 (0.50) GBA1S1PR4S1PR1S1PR3S1PR5
SCHEMBL1381896 0.89 NR1I2 (0.50) GBA1S1PR4S1PR1S1PR3S1PR5
Ammonia Solution, Strong SCHEMBL8225849 0.88 NR1I2 (0.49) GBA1S1PR4S1PR1S1PR3S1PR5
SCHEMBL4947692 0.88 SMN1; SMN2 (0.50) S1PR4S1PR1S1PR3S1PR5KCNH2
SCHEMBL7114016 0.88 SMN1; SMN2 (0.50) S1PR4S1PR1S1PR3S1PR5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0970049-B1 PROCESS FOR THE PRODUCTION OF ENANTIOMERICALLY ENRICHED N-ACYLAZETIDINE-2-CARBOXYLIC ACIDS ASTRAZENECA AB (SE) 2002-06-05 EP disclosed
US-6054594-A Process for the production of enantiomerically enriched N-acylazetidine-2-carboxylic acids ASTRA AB (SE) 2000-04-25 US disclosed
EP-0970049-A1 PROCESS FOR THE PRODUCTION OF ENANTIOMERICALLY ENRICHED $i(N)-ACYLAZETIDINE-2-CARBOXYLIC ACIDS Astra Aktiebolag (SE) 2000-01-12 EP disclosed
WO-1998002417-A1 PROCESS FOR THE PRODUCTION OF ENANTIOMERICALLY ENRICHED N-ACYLAZETIDINE-2-CARBOXYLIC ACIDS ASTRA AKTIEBOLAG (SE) 1998-01-22 WO disclosed